Congratulations to James Fink, graduate student in the Levine Lab, who was one of two recipients to receive the Graduate Student Dissertation Improvement Award (GSDIA).  This $5,000 award was available through a joint partnership with Alexion Pharmaceuticals & GSDIA to support graduate students at UConn & UConn Health whose research in basic biological processes or health applications contributes to discovery, innovation, or the development of products for diagnosis or treatment of rare diseases.

Alexion is a global leader in the development and delivery of breakthrough therapies for patients with severe and life-threatening rare diseases.